CRNX
Crinetics Pharmaceuticals, Inc.
$34.71
-4.92%
-1.71
Notify me if price changes either direction
Buy CRNX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.5B
Enterprise value
2.2B
Trailing PE
-6.6474745008681
Forward PE
-7.8213344
PEG Ratio
-0.36386176215278
Enterprise to EBITDA
-4.113
Enterprise to revenue
123.285
Price to book MRQ
2.7072368
Price to sales TTM
192.10202
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
18.1M
EBITDA
-541617024
Diluted EPS TTM
-5.14
Total Cash (MRQ)
1.3B
Current ratio (MRQ)
18.603
Operating Cash Flow (TTM)
-414172992
CRNX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
